Status:
UNKNOWN
Aneurysm Genetic Risk in Patients With QIB Changes
Lead Sponsor:
University of California, Los Angeles
Conditions:
Brain Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
Intracranial aneurysm rupture is a leading cause of hemorrhagic strokes which carry high mortality and disability rates as well as high healthcare costs. Unruptured intracranial aneurysms (UIA) are co...
Detailed Description
The objective of this study is to investigate intracranial aneurysms that have been followed with clinical 3D aneurysm images and create a matrix that can identify the risk of growth by integrating QI...
Eligibility Criteria
Inclusion
- Patients with unruptured cerebral aneurysms followed yearly using non-invasive imaging techniques including Computed tomography (CT) and Magnetic resonance (MR) angiography.
Exclusion
- Patients with bleeding disorders. Patients who have severe intravenous CT or MR contrast allergy. Patients with evidence of kidney failure. Patients with severe claustrophobia. Patients with religious objections to phlebotomy.
Key Trial Info
Start Date :
December 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 27 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05317169
Start Date
December 12 2018
End Date
September 27 2023
Last Update
May 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90024